Both in Pharmaceuticals
Phathom Pharmaceuticals vs Arvinas
Over the past year PHAT returned −57.9% and ARVN returned −22.2%; their daily moves had a correlation of 0.27.
PHAT −57.9% ARVN −22.2%Growth of $1, one year, split-adjusted
| Metric | PHAT | ARVN |
|---|---|---|
| Price | $5.68 | $7.42 |
| Market cap | $461.7M | $485.2M |
| Today | −1.05% | +4.65% |
| 1 month | −16.2% | +1.5% |
| 6 months | −55.2% | −27.7% |
| Year to date | −65.8% | −37.4% |
| 1 year | −58.6% | −23.7% |
| Revenue growth (YoY) | +71.1% | +1014.7% |
| Gross margin | 78.3% | 96.4% |
| Net margin | −16.4% | 67.8% |
| P/E (TTM) | — | 52.2× |
| Price / sales | 1.7× | 1.5× |
| Net cash | $17.6M | $567.6M |
| Dividend yield | — | — |
| Volatility (60d) | 72.0% | 49.4% |
| Short % of float | 17.5% | 10.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).